89155-71-5Relevant articles and documents
Compound for targeted ubiquitination degradation of ERalpha protein and application thereof
-
, (2020/12/30)
The invention provides a compound with estrogen receptor alpha (ERalpha) activity, and particularly provides a 1,3,5-triazine compound with a general formula (I) or a general formula (II) or a pharmaceutically acceptable salt thereof. The definitions of the groups are as described in the specification. The compound disclosed by the invention has ERalpha degradation activity and can be used for preparing medicines for treating human breast cancer and endometrial cancer.
Compounds with hydroxycarbonyl-halogenoalkyl side chain
-
, (2008/06/13)
The present invention provides a compound consisting of a moiety and a group chemically bonded to said moiety, wherein said moiety contains a compound having low activity following oral administration or its parent scaffold and said group has the followin
Novel stereoselective synthesis of 11β-carbon-substituted estradiol derivatives
Tedesco,Fiaschi,Napolitano
, p. 5316 - 5318 (2007/10/02)
-